An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents.
about
Animal models for posttraumatic stress disorder: An overview of what is used in researchStress weakens prefrontal networks: molecular insults to higher cognitionAlpha-2 receptor agonists for the treatment of posttraumatic stress disorderTargeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive DisordersEmerging drugs for the treatment of anxietyThe role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.The Effects of Stress Exposure on Prefrontal Cortex: Translating Basic Research into Successful Treatments for Post-Traumatic Stress Disorder.Chronic Stimulation of Alpha-2A-Adrenoceptors With Guanfacine Protects Rodent Prefrontal Cortex Dendritic Spines and Cognition From the Effects of Chronic StressGuanfacine Extended Release: A New Pharmacological Treatment Option in Europe.An Update on Posttraumatic Stress Disorder in Children and Adolescents.Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents.Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review.Novel pharmacological treatment strategies for posttraumatic stress disorder.The neurobiology of thought: the groundbreaking discoveries of Patricia Goldman-Rakic 1937-2003.The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD.Emotional dysregulation in a child with attention-deficit/hyperactivity disorder and anxiety: psychopharmacological stategies.Monoamine oxidase A gene methylation and its role in Posttraumatic Stress Disorder - First evidence from the South Eastern Europe (SEE)-PTSD study.Traumatic Brain Injury, Sleep Disorders, and Psychiatric Disorders: An Underrecognized Relationship.Noradrenergic Modulation of Fear Conditioning and Extinction.A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures
P2860
Q26770328-5D38385D-9943-4670-9793-6B0973E9AA75Q26781227-8E64A21C-F10F-49F8-BAE6-3009C6C2F75DQ26795806-8ED55540-3798-4F6B-9E62-D7AC96C05C97Q28076907-FC42B332-5133-48B3-93B0-EC8ED2910F3AQ28083141-148FBB1C-8B07-4B49-828F-ADE67A1584BFQ33598487-DFCE67D7-83F5-48B6-8133-71AF3A4785F1Q34571585-AAB28810-A59B-4FD9-AF40-46583BCF8385Q35046682-DF1F8B9B-5644-4E30-8E5A-42A42C3E441AQ36446854-E50F5462-DEC7-4C24-9949-5E67A802E98FQ38225791-1DA6B2B2-705D-4878-812E-D183C27BF543Q38225962-585108FA-D9FB-440C-9C4B-1650CDC87407Q38654153-5C8856FC-5A4B-44C5-9BD8-F48AEADE449CQ38796437-004EDC6D-B0C1-4115-9537-4CAE343AE33FQ41880359-064CAAAB-4AFD-48E7-9C43-9D16DBF8B7B5Q42070708-BB88F920-EF56-437E-99EB-345697CF556BQ43176477-1798C2C7-1ECD-4421-8FB7-3D32ABD3DDC5Q47571614-0D0A2227-0BE3-48B5-9AC9-6809EA223737Q49805840-5B8012D1-9025-4BE8-90F9-B7AE6D3E783FQ55092559-7604AEE5-3106-4442-A42C-AE46A21DB112Q57178739-2C1C0E6B-0A9A-4EF7-97D3-1D7A3C85A853
P2860
An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
An open-label study of guanfac ...... s in children and adolescents.
@en
type
label
An open-label study of guanfac ...... s in children and adolescents.
@en
prefLabel
An open-label study of guanfac ...... s in children and adolescents.
@en
P2093
P2860
P356
P1476
An open-label study of guanfac ...... ms in children and adolescents
@en
P2093
Alok Banga
Damion J Grasso
Michelle D Slivinsky
P2860
P304
P356
10.1089/CAP.2012.0119
P577
2013-05-01T00:00:00Z